Medical Cannabis and Reduced Prescription Use

Medical Cannabis and Reduced Prescription Use

Medical Cannabis and Reduced Prescription Use

In a soon-to-be published article in the *Journal of the American Medical Directors Association, *University of New Mexico researchers, in collaboration with Industrial Rehabilitation Clinics of Albuquerque, followed patients who enrolled voluntarily in the New Mexico state medical cannabis program and found that they significantly reduced their utilization of scheduled prescription medications in the months following enrollment. All prescriptions for scheduled medications must be reported to the New Mexico Prescription Monitoring Program with opiates and benzodiazepines being the two most common. Based on these prescription records, patients enrolled in the medical cannabis program reduced the monthly average number of prescriptions, types of prescriptions (drug classes), number of prescribers, and number of related pharmacy visits. 71% of medical cannabis program enrollees either ceased or reduced their use of scheduled prescriptions within 6 months of enrolling.

While other studies on medical cannabis have looked at similar state-level outcomes, this study is the first to take the approach of examining individual patients throughout their enrollment in the medical cannabis program and comparing those patients to a comparison group of similar patients who did not enroll in the medical cannabis program.

The findings of this study indicate that once a patient enrolls in the medical cannabis program there is an increased likelihood that the patient will decrease their usage of scheduled medications. These medications include many drugs of abuse such as opiates, benzodiazepines, and sleeping medications. Opiates in particular are in the public discourse because of the danger of overdose, addiction and death.

Stith, S. S., et al “Effects of Legal Access to Cannabis on Scheduled II-V Drug Prescriptions.” (in press). Journal of the American Medical Director’s Association.

US Patients’ Opioid Overdoses Leading to More ICU Admissions & Deaths

Now more and more patients are Opting for CBD instead of Rx pain medications.

A growing number of Americans are needing IC (intensive care) for opioid overdoses and dying after receiving treatment for serious complications, a US study revealed Wednesday.

Opioid-related overdose deaths have doubled since Y 2000 as a worsening epidemic of addiction to both Rx painkillers like oxycodone and illegal drugs like heroin, researchers note in the American Journal of Respiratory and Critical Care Medicine.

Parallel to this worsening trend, opioid overdose admissions requiring treatment in hospital ICU’s intensive care units rose 34% from Y’s 2009 to 2015, the study found.

During this same frame, the death rate for these ICU patients climbed from 7.3 to 9.8%.

Stay tuned…


The following two tabs change content below.
S. Jack Heffernan Ph.D. Funds Manager at HEFFX holds a Ph.D. in Economics and brings with him over 25 years of trading experience in Asia and hands on experience in Venture Capital, he has been involved in several start ups that have seen market capitalization over $500m and 1 that reach a peak market cap of $15b. He has managed and overseen start ups in Mining, Shipping, Technology and Financial Services.

Latest posts by S. Jack Heffernan Ph.D (see all)